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Abstract: Infertility rate documented in Pakistan is 21.9% with only 25% success rate even after procedures like
intracytoplasmic sperm injection (ICSI). This rate is further on the decline with enhancement of female age. We aimed to
observe the effect of female age on oocyte parameters and reproductive outcome after ICSI. It was done by retrospective
analysis of a quasi- experimental design carried out after approval from “Ethical review board of Islamabad clinic
serving infertile couples” from July 2010 to August 2011. The response to ovarian stimulation in (282) females was
assessed on the basis of groups, A, B, C and D with age ranges up to 25years; 25.1 to 30years; 30.1 to 35years and
>35years, respectively. The outcome was assessed as non-pregnant, preclinical abortion and clinical pregnancy groups
on the basis of beta hCG and cardiac activity by trans-vaginal scan. We observed that maximum number of pregnancies
32 (38%) occurred in C group, and least 10 (10%) in group A. There was a statistical reduction in the number of mature
and fertilized oocytes as the age advanced from group C to D (p<0.05).This shows that reduction in maturity and
fertilization of oocytes with advancement of age recommends early referral of couples to assisted reproductive clinics.
Keywords: Female age, infertility, intracytoplasmic sperm injection, ovarian reserve.

INTRODUCTION
Infertility can be defined as incapability of a couple to
enjoy parenthood after unprotected regular intercourse
without any contraception over a period of at least 1-2
years (Rehman et al., 2015). Intracytoplasmic sperm
injection (ICSI) developed especially for treatment of
sterile couples is an infertility treatment in which a sperm
is directly injected in the oocyte (Spandorfer et al., 1998,
Rehman et al., 2014). The procedure deals with in fecund
males and also women of variable age groups and
repeated failures after in-vitro fertilization (IVF) (Palermo
GD et al., 1995). ICSI has resulted in exponential rise in
the number of children born as a result of infertility
treatment plans (Wong and Ledger, 2013).
There is a decline in reproductive functions, ovarian
reserve and its response to stimulation with the
enhancement of maternal age (Marca et al., 2011). The
mean age of women carrying their first child has
increased up to 5years due to a number of factors
including delay in marriages, contraception, and reliance
of assortment to assisted reproductive technology (ART).
Female fertility progresses to a rapid decline after the age
of 35 even after assisted reproductive techniques (ART)
(Baird et al., 2005). Advancing age deleteriously causes a
diminution in ovarian reserve (OR) with a decrease in
number and quality of oocyte, hormones of implantation,
fertilization rate and success after ICSI (Rehman et al.,
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2015 b). The effect of increasing maternal age on fertility
is attributed to poor oocyte parameters that decrease
pregnancy rate and multiplies risk of chromosomal
abnormalities in the embryo (Kim et al., 2013).
The association of maternal age and fertility documented
by Hutterites declared that maximum infertility occurred
after 35 years of age (Hassold et al., 2009). In another
investigation, there was a significant effect of female age
on pregnancy rate and age group of 19-26 year old
women had a higher number of pregnancies as compared
to women belonging to 27-29year old group (Dunson and
Baird, 2004). There was one-sixth the number of
pregnancies in women above 40years of age as compared
to women aged less than 34years (Oehniger et al., 1995).
Since there is lack of available data on effect of female
age on outcome after ICSI, we aimed to investigate the
effects of maternal age on oocyte parameters and
reproductive outcome after ICSI.

MATERIALS AND METHODS
It was a retrospective analysis of a quasi-experimental
study conducted after approval from the Ethical Review
Board of “Islamabad Clinic Serving Infertile Couples”
from June 2010 till August 2011. Data of 282 females
with age 18-41 years, infertility duration of more than 2
years, body mass index (BMI) of 18-27kg/m2and both
functional ovaries exhibiting cycle of 25-35 days with
basal serum FSH level <10IU/mL was collected. Females
with metabolic and endocrine abnormalities, uterine
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fibroids and previous failed attempts of ICSI were
excluded.
Treatment protocol
All subjects were given long desensitizing protocol for
mid luteal pituitary down regulation of ovaries by
subcutaneous administration of GnRHa Decapeptyl 3.75
mg depot or Decapeptyl 0.1mg daily from D-21 of the
preceding cycle. Controlled Ovarian Stimulation was
carried out by using subcutaneous administration of
recombinant FSH (r FSH) 50IU preparation (Puregon
registered; NV Organon, Oss, The Netherlands). The
initiation dose was calculated on the basis of age of the
subject, basal serum FSH concentrations, AFC and BMI.
Dose adjustment was performed by follicular tracking
with trans vaginal scan TVS (7.5MHz probe Aloka 500,
Tokyo Japan) that commenced from the fifth day of COS
on alternate days for assessment of follicular response and
measurement of endometrial thickness. Ovulation
Induction (OI) was decided on the basis of maximum
number of follicles > 18±2mm in diameter on TVS
(around 14±2 days of COS). It was made possible by
administration of human chorionic gonadotrophin (hCG)
by intra muscular injection of 10,000IU of hCG
(Profasi®, Serono, Switzerland). On the day of OI
(dhCG) venous sample was taken for initial estradiol
(E2), and Progesterone (P) estimation (Endometrial
thickness was measured by experienced sonographers in
the midsagittal plane on the day of OI by two-dimensional
ultrasound with a 7.5-MHz probe (Hitachi EUB 525;
Hitachi, Tokyo). Oocytes were retrieved 36 hours after OI
on 14th, 15th or 16th day of COS by vaginal ultrasound
probe with 16G adapter and double lumen oocyte
aspiration needle (Cook Australia; Queens land,
Australia) under short general anesthesia. The follicle
aspirate was immediately placed in to a 60mm labeled
culture dish placed on a thermo plate at 37˚C (Falcon,
Becton Dickinson and company, Franklin Lakes, USA)
and examined under stero microscope (Leica MZ12;
Wetzlar, Gernamy). They were then transferred into the
culture dish containing culture medium GIVF Plus (Vitro
life) overlaid with liquid paraffin oil (Ovoid virtolife,
Tohai Hint Japan) preincubated at 37°C, 5% CO2. All
oocytes were collected in a similar manner. Soon after the
oocyte was found it was transferred to mini incubator (KMINC-1000, Australia). Sperm preparation for ICSI was
made on the day of OPU after obtaining semen sample of
husband in the clinic by masturbation following 3-5 days
of abstinence. It was carried out using sperm Grad
gradient (Vitro life) and preparations were kept in tri gas
incubator (Sanyo MCO-18M- Germany).

culture buffered media on the heated stage of an inverted
phase contrast microscope under 200 x magnifications
(Leica DMIRB, Leica Microsystems, Wetzlar, Germany)
with the help of micro injection pipette.
Assessment of fertilization and cleavage
Fertilization was assessed 16-20 hours after ICSI. Only
normally fertilized (with two pronuclei and two polar
bodies) were considered for eventual embryo transfer.
These were cultured for additional 24-30 hours at 37°C in
fresh CO2 -equilibrated G1 Plus medium till cleavage,
growth and differentiation of embryo.
Assessment of embryo quality
Embryos were evaluated on alternate days and were
graded {Grades 1-5 from best to worst}. The degree of
fragmentation was recognized as the embryonic volume
occupied by enucleated cytoplasmic fragment 322RBM
Online.
Embryo transfer
ET was carried out using Sure View Wallace- Embryo
Replacement Catheter (SIMS-Porter Limited, Hythe Kent,
UK) on Day-five or six after OPU under abdominal
ultrasound guidance. In the procedure cervix was
visualized with the help of a vaginal speculum, which was
then cleansed with culture media. The optimal target for
embryo replacement known as the maximal implantation
potential was identified by abdominal scan. In the first
step of ET, catheter was flushed with Embryo Glue
(Vitrolife), shaped to the degree of angulation of cervix,
loaded with embryos on its tip sand transferred under
ultrasound guidance.
Outcome measures
The outcome of procedure was categorized into three
groups on the basis of serum beta hCG measurement and
TVS performed 14 and 28 days after egg collection
respectively. Non-pregnant females had a negative beta
hCG, preclinical abortion group had positive beta hCG
without any cardiac activity on TVS and clinical
pregnancy group included females who had confirmed
pregnancy by appearance of cardiac activity on TVS. The
outcome was studied in groups A; less than 25years, B;
25. 1 till 30years, C; 30.1 till 35years and D; more than
35years of female age respectively. Distribution of
patients on the basis of age showed that A and B groups
both comprised of 30% females whereas 11% and 29%
had age up to 25years (A) and above 35years (D)
respectively.

STATISTICAL ANALYSIS
Micromanipulation
ICSI was performed 3-6h after oocyte recovery on all
morphologically intact eggs in Metaphase II stage. The
procedure was carried out in labeled microinjection dish
prepared by adding several 10ml droplets of G Gamete
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Interpretation and analysis of data was done via SPSS
(Statistical Packages of Social Sciences) version 15.0.
Results of continuous variables are represented as mean ±
standard deviation. Comparison of female age groups was
Pak. J. Pharm. Sci., Vol.32, No.4, July 2019, pp.1495-1499
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done by one way analysis of variance (ANOVA) with
results declared significant at p-value <0.05.

RESULTS
Table 1 shows outcome of ICSI in 282 females out of
which 162 conceived, 61 (60%) were biochemical and
101 (36%) were clinical pregnancies. Maximum number
of clinical pregnancies 42 (41%) was observed in 30.135years (C) whereas least number 10 (10%) were
observed in less than 25years age group (A). Group D
(35.1 to 40) had maximum preclinical abortions 20 (33%)
in comparison to younger age group {(A);6(10%)}.The
failure to conception was detected to be 12%, 31%,
30%and 27% in groups A, B, C and D respectively. No
significant difference was observed in variables of body
mass index, basal and peak hormones. AFC in age group
D was significantly less (14.4±2.79) as compared to
younger age groups (p<0.001). Table 2 shows ovarian
responsiveness to stimulation in age groups. It was
noticed that there was no statistical difference in number
of oocytes in all age groups whereas mature and fertilized
oocytes were less in group D as compared to group C
(p<0.05). In addition to that, oocyte maturity and
fertilization rate of females aged 35.1 to 40years (Group
D) was lower than other groups; significantly low

(p<0.05) as compared with group C. The association of
oocyte maturity with female age is expressed in fig.,
which narrates a trend towards decline in oocyte maturity
with increase in female age.

DISCUSSION
Female age, BMI, inheritance of OR, basal FSH and
antral follicle count (AFC) have an impact on dosage and
duration of drugs required for favorable number of
oocytes, quality of embryo and hence its implantation of
after ICSI. The number of AFC present in the ovary
depends on the number of primordial follicles present
(Muttukrishna et al., 2005). Although it represents
number of remaining primordial pool in women and
corresponds to the number of oocytes retrieved, there is
still a debate on its influence on quality of oocyte and
embryo quality and hence result of ICSI (Rehman et al.,
2015 b) According to our study, there was significant
effect of age on AFC. Females up to 25years of age (A)
had a higher AFC as compared to other age groups.
Literature reveals decline of AFC with age by a number
of studies done in different decades. AFC declared to be a
reliable marker for OR (Ferraretti et al., 2011). A study
by Gabrielle J.

Table 1: Comparison of outcome after intracytoplasmic Sperm Injection in females of different age groups
Group
A
B
C
D

Female age

Number (282)

Non- pregnant (120)

Up to 25 years
25.1 to 30years
30.1 to 35years
35.1 to 40 years

30 (11%)
84 (30%)
85 (30%)
83 (29%)

14 (12%)
37 (31%)
36 (30%)
33 (27 %)

Preclinical
abortion (61)
6 (10%)
18 (29%)
17 (28%)
20 (33%)

Clinical
pregnancies (101)
10 (10%)
29 (29%)
42* (41%)
20 (20%)

Results of age groups compared on the basis of outcome of ICSI in terms of clinical Pregnancy, Preclinical Abortions and no
conceptions. (Percentages in columns)

Table 2: Comparison of ovarian responsiveness to stimulation in age groups
Total number of injections
required for stimulation
Number of injections in one day
No of oocytes/patient
No of oocytes Metaphase II
No of oocytes fertilized
Oocyte_retrieval_rate
Oocyte maturity rate
Fertilization Rate

A Upto 25 years

B 25.1 to 30years

C 30.1 to 35years

D 35.1 to 40 years

56.71 ± 8.582

56.34 ± 8.193

58.1 ±11.206

57.35 ± 7.924

4.02 ± 0.676
7.97 ±2.189
7.4 ± 2.372
6.13 ± 1.833
98.37 ± 3.329
92.64 ± 16.18
77.11 ± 12.301

3.94 ±0.612
7.79 ±1.715
7.19 ± 1.917
5.98 ± 1.505
99.2 ±2.481
92.85 ± 16.617
77.4 ±13.642

4.05 ± 0.79
7.71 ± 1.419
7.08 ± 1.74
5.89 ± 1.397
98.96 ± 4.883
94.52 ± 15.405
78.92 ± 13.179

4.02 ± 0.604
7.48 ± 1.664
7.01 ±2.081*
4.90 ± 1.679*
99.05 ± 3.169
91.54 ± 21.202*
77.33 ± 17.949*

Values expressed as Mean ± SD
Groups compared by one way analysis of variance
 p value <0.05 for comparison of group D with C
 Oocyte retrieval rate (%) = Total number of follicles at ultrasound/number of oocytes retrieved × 100 
 Oocyte maturity rate(%) = Total number of metaphase II oocytes / Total number of oocytes retrieved × 100 
 Fertilization rate (%) = Total number of 2 pronuclei/ Total number of oocytes microinjected × 100 
Pak. J. Pharm. Sci., Vol.32, No.4, July 2019, pp.1495-1499
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Scheffer et al. showed that the AFC by the age of 37
reduces every year by 4.8% and with further increase in
age AFC reduces by 11.7% (Scheffer et al., 1999). A
prospective study that was conducted by Ming-Yang
Chang et al. portrayed that women with lower AFC had
higher rate of miscarriages (Chang et al., 1998). Our
results are supported by a study done by Antonio La
Marca et al which illustrated that there was linear
decrease in AFC with increasing age (Marca et al., 2011).
In our study, a decrease in number of retrieved oocytes
was observed with advancement in maternal age. This is
in contrary to work conducted by Mille r JE and Smith TT
2001 in which no considerable differences in relation to
number of recovered oocytes, maternal age and
percentage of fertilized oocytes during ICSI was observed
(Miller and Smith, 2001).
Advancing maternal age did show a great impact on the
number of pregnancies by our group. Silber SJ et al.
conducted an investigation which proved that age of
female had no significant effect on the number of
successful pregnancies (Silber et al., 1997). The rate of
preclinical abortions in group D was considerably higher
which is in contrary to the results of a study in which
females undergoing fertilization by ICSI had similar rates
of abortions irrespective of age (Ulug U et al., 2006).
These results are supported by Staessen C. et al. which
showed a higher number of pregnancy loss after assisted
reproductive techniques (ART) with advancement of age
(Staessen et al., 2004).
This is a unicentric study with a very small sample size,
however is the first study in Pakistan to draw evidencebased attention on awareness of age on reproductive
outcome. The information obtained will help the women
to know about the failure of treatment procedures,
spontaneous pregnancy loss and likelihood of
chromosomal abnormalities with progressive ageing and
postponement of treatment.
No. of oocytes Metaphase II

Fig. 1: Effect of age on maturity of oocytes.

CONCLUSION
Female age is the noteworthy variable that can be blamed
for poor reproductive outcome as a result of changes that
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lead to failure of maturation of oocyte and fertilization
after intracytoplasmic micro injection of spermatozoa.
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